Singapore
Principal investigator in gerontology, specialist in geriatrics / internal medicine and senior manager to prevent age related diseases and prolonging healthspan.
Chi Longevity is the global Centre of Excellence for evidence based biological age discovery and reversal, it opened the inaugural medical suite in Singapore in February 2023. In December 2024, the second clinic opened at the Four Seasons Hotel Singapore. www.ChiLongevity.com
Oon Chiew Seng Professor in Medicine and Functional Ageing Singapore's population is rapidly ageing - people are living longer, while the birth rate remains low. By 2030, one in four Singaporeans will be 65 years and above, twice the current ratio. In addition, direct costs of elderly healthcare in Singapore are projected to rise tenfold to more than $66 billion. Given the increased prevalence of age-related disease that accompanies the ageing population, this issue may represent the biggest medical challenge of the 21st century. Ageing is the most common and biggest risk factor for most chronic diseases including Alzheimer’s disease, cardiovascular disease, frailty, most forms of cancer and diabetes. The Centre for Healthy Longevity is a multi-disciplinary hub that integrates research and clinical care, providing a holistic strategy to promote healthy living throughout the ageing process, from effective disease prevention in the healthy to novel and compassionate end-of-life care.
The Healthy Longevity Medicine Society is the international medical Society of Longevity Medicine promoting the highest standards of clinical practice and of interdisciplinary clinical and scientific collaboration. Healthy Longevity Medicine is optimizing healthspan by targeting ageing processes across the lifespan
ANZSSFR is a professional, scientific society dedicated to the promotion of clinical, basic and translational research on sarcopenia and frailty in Australia and New Zealand. We aim to disseminate current knowledge of sarcopenia and frailty, along with deepening the understanding of muscle, bone and joint disease.
ANZSSFR is a professional, scientific society dedicated to the promotion of clinical, basic and translational research on sarcopenia and frailty in Australia and New Zealand. We aim to disseminate current knowledge of sarcopenia and frailty, along with deepening the understanding of muscle, bone and joint disease. Our research on sarcopenia, osteoporosis and their combination, often culminating in disability and frailty, aims to identify, prevent and treat these conditions with the goal to translate evidence-based research and knowledge into clinical and real-world practice to better support older people in ageing well. We believe that understanding the links between sarcopenia, frailty and osteoporosis assists in designing research and improving interventions in clinical practice that may help older people to reduce their risk of disease and live independently and without disability into old age. ANZSSFR also acts to represent the needs of its members through annual scientific meetings, as well as the wider clinical and lay community through advocacy and interaction with government, key stakeholders and related societies.